Friday, July 20, 2018
Redactor's Choice
You are here: Home / Categories / Health & Beauty (page 74)

Health & Beauty

ExAblate receives extended CE Mark Certification for benign and cancerous bone tumors


InSightec Ltd, the leader in MRI guided Focused Ultrasound therapy, has announced that its ExAblate(R) systems have received an extended European CE Mark for the local treatment of cancerous and benign primary and secondary bone tumors, including but not limited to multiple myeloma, bone metastases, osteoid osteoma as well as facet joint back pain, The CE mark applies to the ExAblate 2000 and 2100 as well as the ExAblate 2100 Conformal Bone System. The CE mark was based on additional published clinical evidence. ExAblate combines therapeutic a... Read More »

Eliquis® (apixaban) demonstrated comparable efficacy and significantly lower rates of major bleeding in patients compared to current standard of care for the treatment of acute venous thromboembolism


PRINCETON, N.J. and NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the results of the six month Phase 3 AMPLIFY trial of 5,395 patients with acute venous thromboembolism (VTE), which includes symptomatic deep vein thrombosis (DVT) and/or pulmonary embolism (PE). In this trial, Eliquis as a single-agent achieved the primary efficacy endpoint of noninferiority to current standard of care (initial parenteral enoxaparin treatment overlapped with warfarin therapy) in the reduction of t... Read More »

High Level Panel Debate – ‘Personalised Medicine – Hype or Hope’, at 2nd European Colorectal Cancer Patient Conference (CCPC 2013).


Colorectal cancer (also known as bowel cancer) is the second most common malignancy in Europe. More than 413,000 people are diagnosed with colorectal cancer every year, resulting in more than 212,000 deaths. Yet colorectal cancer is preventable in many cases and highly treatable if diagnosed early. CCPC 2013 also calls for cancer therapies to be provided to all colorectal cancer patients throughout Europe. Some patients currently have to pay for cancer therapies which are provided free in other European countries. Jola Gore-Booth, EuropaColon... Read More »

Poland – a new player in medical tourism sector


Treat teeth and get implants in dental clinics, take a cure in Polish sanatoriums? Will women fly to Central Europe, instead of Thailand, to undergo blepharoplasty, remove access fat or indulge in beauty treatments? It's possible. Polish government programme - promoting Poland as a country worth visiting for health treatment, rehabilitation, diagnosis, improving looks is effective. A visible national stand and stands of individual facilities at three consecutive trade fairs: Miami 2012, Moscow and Monaco in March 2013, resulted in Poland being... Read More »

World Federation of Hemophilia marks historic anniversary for the Global Bleeding Disorders Community


Fifty years ago, on June 25, 1963, the WFH held its first meeting in Copenhagen, Denmark. Working with leaders from a group of national patient associations, Frank Schnabel, WFH founder, convened this global meeting. Representatives from 12 countries attended, including Argentina, Australia, Belgium, Canada, Denmark, France, Germany, Japan, the Netherlands, Sweden, the United Kingdom, and the United States. As the WFH marks its 50th anniversary, the global bleeding disorders community reflects on the many accomplishments that have been made. H... Read More »

New Boston scientific pacemaker family features technology for adapting pacing to respiration


These pacemakers monitor respiration, adjust pacing accordingly, and support insight into the patient's overall heart failure status. Comprising of the INLIVEN[TM] cardiac resynchronization therapy pacemaker (CRT-P) that synchronizes the heart chambers, and the VITALIO[TM] and FORMIO[TM] pacing systems, the new family of devices offers clinicians a comprehensive set of tools for the management of heart failure and related comorbidities. Pacing systems are designed to treat bradycardia, a condition in which the heart beats too slowly, depriving... Read More »

1 million diabetic patients in Dutch uncertainty


Somewhat However, the lives of people with diabetes has everything except security for the future. Despite the treatment of diabetes may still be a question of very high blood sugar which have a destructive effect on the blood vessels. This can lead to both functional and structural problems in the small blood vessels, such as disturbed blood circulation in the feet, legs or eyes (retinopathy). Most developing diabetes within 15 years after diagnosis of diabetes, retinopathy. * When retinopathy is often involves bleeding in the retina (retina) ... Read More »

AmVac receives two EU grants for the development of Novel Vaccines


The projects are joint initiatives of AmVac, other European companies and research institutes with leading expertise in vaccine design and development. Total funding for all participating partners is approximately EUR 6 million and EUR 5.5 million, respectively, over five years. Within the funding periods, both vaccines are expected to complete Phase I clinical trials. The first project aims to develop a universal flu vaccine that can be used over several years. While traditional flu vaccines target highly variable antigens on the virus' surfa... Read More »

Chronic Kidney Disease: Reducing Risks of Progression – Prismic Pharmaceuticals Secures Exclusive Licensing Rights


Commenting on securing the rights to this important new agent, Prismic's Chief Medical Officer, Dr. Teo Forcht Dagi, said, "Inflammation and oxidative stress play a key role in the induction and the progression of Chronic Kidney Disease (CKD). This is particularly so in diabetic patients, and it is most likely that inflammation is a major factor in the pathogenesis and progression of diabetic nephropathy. In addition, an increase in inflammatory cytokine levels in diabetes may increase oxidative stress as renal injury becomes more pronounced, t... Read More »

Avon to Present at the Deutsche Bank dbAccess 10th Annual Global Consumer Conference


The webcast and related slide presentation can be accessed at and will be archived at that site for one year. About Avon Avon, the company for women, is a leading global beauty company, with nearly $11 billion in annual revenue. As one of the world's largest direct sellers, Avon is sold through more than 6 million active independent Avon Sales Representatives. Avon products are available in over 100 countries, and the product line includes color cosmetics, skincare, fragrance, fashion and home products, featuring s... Read More »

Scroll To Top